Irodalmi hivatkozások a tanulmányokhoz

1. MOJZISOVÁ, G., PETRÁSOVÁ, D., KOPROVICOVA, J.: Flavonoidy s antioxidacnyrni úcinkami a ich vplyv na zdravie iudí. Sloaakofnrrrta Rev, 9, 1999, c. 1, s. 35
- 37.
2. REILLY, P. M., SCHILhER, H. J., BULKLEY, G. B.: Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites.
Air: J Stirg, 161, 1991, s. 488 - 503.
3. TOMKO, J.: Farmakognózia. Martin: Osveta, 1989, s. 90 - 235.
4. MIDDLETON, E., KANDASWAMI, CH., THEOHARIDES, T. C.: The effects of plant flavonoids on mammalian cells: Implication for inflammation, heart
disease and cancer. Pharrrtacol Rev, 52, 2000, s. 673 - 751.
5. KUO, S. M., LEAVIT, P. S., LIN, C. P.: Dietary flavonoids interact with trace metals and affect metallothionein level in human intestinal cells. Biol Trace Element
Res, 62, 1998, s. 135 - 153.
6. WAGNER, H., FARKAS, L.: Synthesis of flavonoids. New York: Academic Press, 1975, s. 127 - 213.
7. NARAYANA, K. R., REDDY, M. S., CHALUVADI, M. R., KRISHNA, D. R.: Bioflavonoids classification, pharmacologic, biochemical effects and therapeutic
potential. Indian. J Pharnurcol, 33, 2001, s. 2 - 16.
8. LUGASI, A.: Potential health-protective effects of food derived flavonoids. Orv Hetil, 6, 2000, s. 1751 - 1760.
9. MATSUZAKI, Y., KUROKAWA. N., TERM, S., MATSUMURA, Y., KOBAYASHI, N., OKITA, K.: Cell death induced by baicalein in human
hepatocellular carcinoma cell. Res, 87, 1996, s. 170 - 177.
10. CALOMME, M., PIETERS, L., VLIETINCK, A., VANDEN BERGHE, D.: Inhibition of bacterial mutagenesis by citrus flavonoids. Plartta Med, 62,
1996, s. 222-226.
11. READ, M. A.: Flavonoids naturally occuring anti-inflamatory. Arrt I Patlrol, 147, 1995, s. 235 - 237.
12. PEREZ, R. M., ZAVALA, M. A., PEREZ, S., PEREZ, C.: Antidiabetic effect of compounds isolated from plants. Phytomed, 5, 1998, s. 55 - 75.
13. YAMAMURA, S., OZAWA, K., ONTANI, K., KASAI, R., YAMASAKI, K.: Antihistaminic flavones and aliphatic glycosides from Mentha
spicata. Phytochent, 48, 1998, s. 1 3 1 - 1 3 6 .
14. LIM, B. 0., YU, B. P., CHO, S. I., HER, E., PARK, D. K.: The inhibition by quercetin and ganhuangenin on oxidatively modified low
density lipoprotein. Phytother Res, 12, 1998, s. 340 - 345.
15. CATAPANO, A. L.: Antioxidant effect of flavonoids. Angiology, 48, 1.997, s. 39 - 44.
16. DURACKOVÁ, Z.: Volné radikdly a ant ioxidanty v r t tedicíne (1). 1. vydanie. Bratislava: Slovak Academic Press, 1998, 285 s.
17. DURACKOVÁ, Z.: Voiné radikdly a antioxidnnty v medic(ne (II). 1. vydanie. Bratislava: Slovak Academic Press, 1999, 315 s.
18. KANTER, M.: Free radicals, exercise and antioxidant supplementation. Proc Nutr Soc, 12, 1998, s. 9 - 13.
19. NATHAN, C.: Nitr ic oxide as a product of mammalian cells. Adv Pharmacol, 34, 1995, s. 45 - 69.
20. KONG, A. N., YU, R., CHEN, C., 1v4ANDLEKAR, S., PRIMIANO, T.: Signal transduction events elicited by natural products: role of
MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch Pharm Res, 23, 2000, s. 1 - 16.
21. BORS, W., HELLER, W., MICHEL, C.: Flavonoids as antioxidants: Determination of radikal-scavenging efficiencies. Meth Enzyrnol, 186,
1990, s. 343 - 355.
22. JOVANOVIC, S. V., SIMIC, M. G.: Antioxidants in nutrition. Acad Sci, 899, 2000, s. 326 - 334.
23. LAMSON, D. W., BRIGNALL, M. S.: Antioxidants and cancer, part 3: quercetin. Altern Med Rev, 5, 2000, s. 196 -208.
24. ARORA, A., NAIR, M. G., STRASBURG, G. M.: Structure-activity relationships for antioxidant activities of a series of flavonoids in a
liposomal system. Free Rod Biol Med, 24, 1998, s. 1355 - 1363.
25. STEINBRECHER, U. P., ZHANG, H., LOUGHEED, M.: Role of oxidatively modified LDL in atherosclerosis. Free Rod Biol Med, 9, 1990, s.
155 - 161.
26. VAN DE VIJVER, L. P. L., KARDINAAL, A. F. M., BROBBEE, D. E., PRINCEN, H. M. G., VAN POPPEL, G.: Lipoprotein oxidation,
antioxidants and cardiovascular risk: epidemiologic evidence. Prostaglandins Leucot. Essent Fatty Acids, 57, 1997, s. 479 - 487.
27. ARORA, A., BYREM, T.-, M., NAIR, N. G., STRASBURG, G. M.: Modulation of liposomal membrane fluidity by flavonoids and
isoflavonoids. Arch Biochem Biophys, 373, 2000, s. 102 - 109.
28. KNET, P., JARVINEN, R., SEPPF.NEN, R., HELIOVAARA, M., TEPPO, L., PUKKALA, E., AROMAA, A.: Dietary flavonoids and the
risk of lung cancer and other malignant neoplasms. Ant J F.pidentiol, 146, 19,97, s. 223 - 230.
29. EASTWOOD, M. A.: Interaction of dietary antioxidants in vivo: how fruits and vegetables prevent disease? Adv Ntttr Res, 8, 1999, s. 119
- 145.
30. TREVISANATO, S. I., KIM, Y. I.: Tea and health. Nutr Rev, 58, 2000, s. 1 - 10.
31. TIUKAVKINA, N. A., RULENKO, L A., KOLESNIK, IU. A.: Natural flavonoids as dietary antioxidants and biologically active additives. Vopr
Pitan, 2, 1996, s. 33 - 38.
32. PETERSON, J., DWYER, J.: Flavonoids: dietary occurrence and biochemical activity. Nuír Res, 18, 1998, s. 1995 - 2018.
33. MINISCALO, A., LUNDAHL, J., REGARD, C. G.: Inhibition of dihydropyridine metabolism in rat and human liver microsomesby
flavonoids found in grapefruit juice. J Pltnrnincol Exp Ter, 261, 1992, s. 1195 - 1199.
34. ANTON, R., BERETZ, A.: Flavonoids: antithrombotic agents or nutrients? Bull Acad Nat Med, 174, 1990, s. 709 - 7 1 7 .
35. PIETTA, P. G.: Flavonoids as antioxidants. J Nat Prod, 63, 2000, s. 1035 - 1042.
36. WANG, H. X., NG, T. B.: Natural products with hypoglycemic, hypotensive, hypocholesterolemic, antiatherosclerotic and antithrombotic
activities. Life Sci, 65, 1999, s. 2663 -2677.
37. YOSI3IDA, H., ISHIKAWA, T., HOSOAI, H., SUZUKAWA, M.: Inhibitory effect of tea flavonoids on the ability of cells to oxidize low density
lipoprotein. Biochem Pharrrtacol, 58, 1999, s. 1695 - 1703.
38. MATTHEE, G., WRIGHT, A. D., KONG, G. M.: HIV reverse transcriptase inhibitors of natural origin. Plan to Med, 65, 1999, s. 493 - 506.